NM_006892.4:c.-274C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006892.4(DNMT3B):​c.-274C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0209 in 157,506 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 46 hom., cov: 32)
Exomes 𝑓: 0.031 ( 5 hom. )

Consequence

DNMT3B
NM_006892.4 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.28

Publications

1 publications found
Variant links:
Genes affected
DNMT3B (HGNC:2979): (DNA methyltransferase 3 beta) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined. [provided by RefSeq, May 2011]
DNMT3B Gene-Disease associations (from GenCC):
  • immunodeficiency-centromeric instability-facial anomalies syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • facioscapulohumeral muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency-centromeric instability-facial anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 20-32762432-C-T is Benign according to our data. Variant chr20-32762432-C-T is described in ClinVar as Benign. ClinVar VariationId is 338146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0206 (3118/151724) while in subpopulation NFE AF = 0.0303 (2057/67832). AF 95% confidence interval is 0.0292. There are 46 homozygotes in GnomAd4. There are 1462 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 46 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006892.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
NM_006892.4
MANE Select
c.-274C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 23NP_008823.1Q9UBC3-1
DNMT3B
NM_006892.4
MANE Select
c.-274C>T
5_prime_UTR
Exon 1 of 23NP_008823.1Q9UBC3-1
DNMT3B
NM_175848.2
c.-274C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 22NP_787044.1Q9UBC3-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
ENST00000328111.6
TSL:1 MANE Select
c.-274C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 23ENSP00000328547.2Q9UBC3-1
DNMT3B
ENST00000348286.6
TSL:1
c.-274C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 20ENSP00000337764.2Q9UBC3-3
DNMT3B
ENST00000328111.6
TSL:1 MANE Select
c.-274C>T
5_prime_UTR
Exon 1 of 23ENSP00000328547.2Q9UBC3-1

Frequencies

GnomAD3 genomes
AF:
0.0206
AC:
3118
AN:
151616
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00445
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.0171
Gnomad ASJ
AF:
0.0539
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00827
Gnomad FIN
AF:
0.0233
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0303
Gnomad OTH
AF:
0.0236
GnomAD2 exomes
AF:
0.0124
AC:
4
AN:
322
AF XY:
0.0106
show subpopulations
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0132
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0311
AC:
180
AN:
5782
Hom.:
5
Cov.:
0
AF XY:
0.0284
AC XY:
113
AN XY:
3984
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
48
American (AMR)
AF:
0.00
AC:
0
AN:
38
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
6
AN:
48
East Asian (EAS)
AF:
0.00
AC:
0
AN:
170
South Asian (SAS)
AF:
0.0188
AC:
11
AN:
584
European-Finnish (FIN)
AF:
0.0978
AC:
9
AN:
92
Middle Eastern (MID)
AF:
0.0227
AC:
1
AN:
44
European-Non Finnish (NFE)
AF:
0.0321
AC:
146
AN:
4550
Other (OTH)
AF:
0.0337
AC:
7
AN:
208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.566
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0206
AC:
3118
AN:
151724
Hom.:
46
Cov.:
32
AF XY:
0.0197
AC XY:
1462
AN XY:
74178
show subpopulations
African (AFR)
AF:
0.00443
AC:
184
AN:
41504
American (AMR)
AF:
0.0170
AC:
260
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.0539
AC:
187
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5126
South Asian (SAS)
AF:
0.00828
AC:
40
AN:
4830
European-Finnish (FIN)
AF:
0.0233
AC:
242
AN:
10404
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.0303
AC:
2057
AN:
67832
Other (OTH)
AF:
0.0233
AC:
49
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
156
311
467
622
778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0257
Hom.:
6
Bravo
AF:
0.0198
Asia WGS
AF:
0.00690
AC:
24
AN:
3346

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
11
DANN
Benign
0.87
PhyloP100
-1.3
PromoterAI
-0.027
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139762513; hg19: chr20-31350238; API